Clinical Trial Update: Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients

View source ↗

Summary

A completed trial evaluated an apoptotic biomarker test to predict late toxicities after radiotherapy in breast and prostate cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Breast Cancer, Prostate Cancer | Status: COMPLETED